Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK

Insulin Degludec ◽

The Uk ◽

Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom

Value in Health ◽

10.1016/j.jval.2013.08.685 ◽

2013 ◽

Vol 16 (7) ◽

pp. A442

Author(s):

B. Chubb ◽

M. Evans ◽

M. Wolden ◽

T. Christensen ◽

J. Gundgaard

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Insulin Degludec ◽

The United Kingdom ◽

Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals

Journal of Clinical & Translational Endocrinology ◽

10.1016/j.jcte.2015.12.002 ◽

2016 ◽

Vol 3 ◽

pp. 14-20

Author(s):

Elizabeth Mary Lamos ◽

Lisa M. Younk ◽

Donna B. Tate ◽

Stephen N. Davis

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Pharmacokinetics And Pharmacodynamics ◽

Glargine Insulin ◽

Analog Insulin ◽

Insulin Glulisine ◽

Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus

Diabetes Therapy ◽

10.1007/s13300-013-0048-5 ◽

2013 ◽

Vol 4 (2) ◽

pp. 461-472 ◽

Cited By ~ 21

Author(s):

Yoshiki Kusunoki ◽

Tomoyuki Katsuno ◽

Kana Miyakoshi ◽

Takashi Ikawa ◽

Rie Nakae ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Degludec

COST ANALYSIS OF INSULIN DEGLUDEC IN COMPARISON WITH INSULIN GLARGINE U100 IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM

Value in Health ◽

10.1016/j.jval.2016.03.1285 ◽

2016 ◽

Vol 19 (3) ◽

pp. A200

Author(s):

A.D. Piedade ◽

L. Paladini ◽

J.S. Alves ◽

T.d. Gonçalves ◽

F. Griciunas

Keyword(s):

Diabetes Mellitus ◽

Health Care ◽

Type 1 Diabetes ◽

Cost Analysis ◽

Insulin Glargine ◽

Health Care System ◽

Insulin Degludec ◽

Private Health Care

Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL−1 and Glargine 100 U mL−1 in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study

Diabetes Therapy ◽

10.1007/s13300-015-0115-1 ◽

2015 ◽

Vol 6 (2) ◽

pp. 143-152 ◽

Cited By ~ 12

Author(s):

Hideaki Jinnouchi ◽

Masayoshi Koyama ◽

Atsushi Amano ◽

Yoshinori Takahashi ◽

Akira Yoshida ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Pilot Study ◽

Insulin Glargine ◽

Continuous Glucose Monitoring ◽

Glucose Monitoring ◽

Japanese People ◽

Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen

Terapevticheskii arkhiv ◽

10.17116/terarkh2015871042-49 ◽

2015 ◽

Vol 87 (10) ◽

pp. 42

Author(s):

N. V. Efremova ◽

L. L. Bolotskaya ◽

D. S. Atarshchikov ◽

O. N. Bondarenko ◽

A. V. Ilyin ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Young Patients ◽

Insulin Analogues ◽

Insulin Glulisine ◽

Basal Bolus ◽

Observational Program

Insulin Glargine Dose and Weight Changes in Underweight, Normal Weight, and Overweight Children Newly Diagnosed with Type 1 Diabetes Mellitus

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1002/phar.2281 ◽

2019 ◽

Vol 39 (7) ◽

pp. 741-748

Author(s):

Bethany Sharpless Chalk ◽

Janet Crane ◽

Gayane Yenokyan ◽

Erika May Pineda ◽

Carlton K.K. Lee

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Normal Weight ◽

Newly Diagnosed ◽

Overweight Children ◽

Weight Changes

PDB7 THE RELATIVE COST EFFECTIVENESS OF INSULIN GLARGINE VERSUS NPH INSULIN IN THE UK IN PEOPLE WITH TYPE 1 DIABETES

Value in Health ◽

10.1016/s1098-3015(10)63277-9 ◽

2006 ◽

Vol 9 (6) ◽

pp. A225-A226

Author(s):

P McEwan ◽

CD Poole ◽

P Holmes ◽

AP Tetlow ◽

CJ Currie

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Relative Cost ◽

Nph Insulin ◽

Relative Cost Effectiveness ◽

The Uk

Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation

Applied Health Economics and Health Policy ◽

10.1007/s40258-018-0379-5 ◽

2018 ◽

Vol 16 (3) ◽

pp. 357-366 ◽

Cited By ~ 2

Author(s):

William J. Valentine ◽

Kate Van Brunt ◽

Kristina S. Boye ◽

Richard F. Pollock

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Effectiveness Evaluation ◽

Insulin Regimen ◽

Regular Human Insulin ◽

Analog Insulin

729-P: Efficacy and Safety of Mylan Insulin Glargine Products (MYL-1501D) from Two Manufacturing Processes (Process V and Process VI) in Combination with Insulin Lispro in Subjects with Type 1 Diabetes Mellitus

Diabetes ◽

10.2337/db21-729-p ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 729-P

Author(s):

YARON RAITER ◽

THOMAS BLEVINS ◽

BIN SUN ◽

ANOOP CHULLIKANA ◽

GOPINATH RANGANNA ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Lispro ◽

Manufacturing Processes ◽

Efficacy And Safety